|
Prosthetic Joint Infection After Primary Total Knee Arthroplasty: Incidence, Microbiology and Risk Factors |
1F32AI164809-01A1 |
|
NIAID |
2022 |
|
A New Approach to Treat Prosthetic Joint Infections with a ClpP Activating Antibiotic |
5R44AI157081-02 |
|
NIAID |
2022 |
|
Validating Inhibitors of the Immunomodulatory Sphingosine 1-Phosphate Transporter SPNS2 |
5 R01 AI148178-02 |
SCHWAB, SUSAN RUTH |
NIAID |
2021 |
|
The role of Staphylococcus aureus aggregate formation in establishing biofilms in chronic orthopaedic periprosthetic joint infection. |
5R01GM124436-03 |
STOODLEY, PAUL |
NIAID |
2020 |
|
IN VIVO PRODUCTION OF A POTASSIUM CHANNEL INHIBITOR FOR IMMUNOMODULATION |
1R21AI136876-01A1 |
BEETON, CHRISTINE |
NIAID |
2019 |
|
MECHANISMS OF IL-6 MEDIATED T CELL PATHOGENESIS IN AUTOIMMUNITY |
5R01AI132774-03 |
BUCKNER, JANE HOYT |
NIAID |
2019 |
|
MECHANISMS OF IL-6 MEDIATED T CELL PATHOGENESIS IN AUTOIMMUNITY |
5R01AI132774-02 |
BUCKNER, JANE HOYT |
NIAID |
2018 |
|
UNIVERSITY OF MICHIGAN AUTOIMMUNITY CENTER OF EXCELLENCE, CLINICAL RESEARCH PROGR |
5UM1AI110557-05 |
FOX, DAVID ALAN |
NIAID |
2018 |
|
MECHANISMS OF IL-6 MEDIATED T CELL PATHOGENESIS IN AUTOIMMUNITY |
1R01AI132774-01 |
BUCKNER, JANE HOYT |
NIAID |
2017 |
|
UNIVERSITY OF MICHIGAN AUTOIMMUNITY CENTER OF EXCELLENCE, CLINICAL RESEARCH PROGR |
5UM1AI110557-04 |
FOX, DAVID ALAN |
NIAID |
2017 |